Perceptions of barriers to cervical cancer screening among Saudi women: A cross-sectional study
Abstract
In the Kingdom of Saudi Arabia (KSA), Cervical Cancer (CC) ranked fourth in incidence and associated mortality among all cancers, with a mean age incidence of 61 years. This study evaluates the perceived barriers to CC screening among Saudi women in Najran city, KSA. A cross-sectional study was conducted in Najran/ KSA, involving 1085 females. The data collection instrument comprised three main parts: basic data questionnaire, women’s knowledge regarding CC screening, assessment of health belief model scale for CC, and Pap smear test. Data collection started through an online survey from the beginning of October 2021 till the end of January 2022. Data analyses were performed using the Statistical IBM software, version 23 (IBM Corp., Armonk, N.Y., USA). The results showed that fear of bad results (68.9%), cost of treatment (58.8%), embarrassment (59.9%), and preference for female physician (47.4%) among several others were the barriers to CC screening identified by women Over 61% of the participants had a moderate barrier to CC screening, and 24.8% had high perceived barriers. Ordinal logistic regression shows that age, higher education, high monthly income, positive family history for CC, and adequate CC screening knowledge are positive predictors of low CC screening barriers (p˂0.05). Increasing number of deliveries and parities was a negative predictor for low CC screening. CC screening barriers are still high among Saudi females. Some demographic variables may predict low CC screening barriers, and health care providers should consider these variables during CC preventive and educational programs. (Afr J Reprod Health 2022; 26[7s]: 33-42).
Full Text:
PDFReferences
Bray F Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12. Erratum in: CA Cancer J Clin. 2020 Jul;70(4):313. PMID: 30207593.
Annual Cancer Incidence Report for Saudi Cancer Registry (SCR) (2014). Available from https://nhic.gov.sa/ eServices/Documents/2014.pdf. [Accessed on 22-10-2018].
Tsikouras P, Zervoudis S, Manav B, Tomara E, Iatrakis G, Romanidis C, Bothou A and Galazios G. Cervical cancer: screening, diagnosis and staging. J BUON. 2016 Mar-Apr;21(2):320-5. PMID: 27273940.
Yousif HM, Albasri AM, Alshanqite MM and Missawi HM. Histopathological Patterns and Characteristics of Abnormal Cervical Smear in Madinah Region of Saudi Arabia. Asian Pac J Cancer Prev. 2019 May 25;20(5):1303-1307. doi: 10.31557/APJCP.2019.20.5.1303. PMID: 31127881; PMCID: PMC6857873.
Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020 Jul;40(5):602-608. doi: 10.1080/01443615.2019.1634030. Epub 2019 Sep 10. Erratum in: J Obstet Gynaecol. 2020 May;40(4):590. PMID: 31500479; PMCID: PMC7062568.
McNamara M, Batur P, Walsh JME and Johnson KM. HPV Update: Vaccination, Screening, and Associated Disease. J Gen Intern Med. 2016 Nov;31(11):1360-1366. doi: 10.1007/s11606-016-3725-z. Epub 2016 May 16. PMID: 27184752; PMCID: PMC5071275.
Rerucha CM, Caro RJ and Wheeler VL. Cervical Cancer Screening. Am Fam Physician. 2018 Apr 1;97(7):441-448. PMID: 29671553.
Al-Mandeel HM, Sagr E, Sait K, Latifah HM, Al-Obaid A, Al-Badawi IA, Alkushi AO, Salem H, Massoudi NS, Schunemann H, Mustafa RA and Brignardello-Petersen R. Clinical Practice Guidelines on the Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention in Saudi Arabia. Ann Saudi Med. 2016 Sep-Oct;36(5):313-320. doi: 10.5144/0256-4947.2016.313. PMID: 27710981; PMCID: PMC6074318.
Al-Mandeel HM, Sagr E, Sait K, Latifah HM, Al-Obaid A, Al-Badawi IA, Alkushi AO, Salem H, Massoudi NS, Schunemann H, Mustafa RA and Brignardello-Petersen R. Clinical Practice Guidelines on the Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention in Saudi Arabia. Ann Saudi Med. 2016 Sep-Oct;36(5):313-320. doi: 10.5144/0256-4947.2016.313. PMID: 27710981; PMCID: PMC6074318.
Salem MR, Amin TT, Alhulaybi AA, Althafar AS and Abdelhai RA. Perceived Risk of Cervical Cancer and Barriers to Screening among Secondary School Female Teachers in Al Hassa, Saudi Arabia. Asian Pac J Cancer Prev. 2017 Apr 1;18(4):969-979. doi: 10.22034/APJCP.2017.18.4.969. PMID: 28545195; PMCID: PMC5494247.
11.General Authority for statistics. Saudi Demography Survey 2016. Available at: https://www.stats.gov.sa/sites/default/files/en-demographic-research-2016_2.pdf. [Accessed on 15-3-2021].
Wood B, Taljaard M, El-Khatib Z, McFaul S, Graham ID and Little J. Development, and field testing of a tool to elicit women's preferences among cervical cancer screening modalities. J Eval Clin Pract. 2019 Dec;25(6):1169-1181. doi: 10.1111/jep.13258. Epub 2019 Aug 18. PMID: 31423705.
Guvenc G, Akyuz A and Açikel CH. Health Belief Model Scale for Cervical Cancer and Pap Smear Test: psychometric testing. J Adv Nurs. 2011 Feb;67(2):428-37. doi: 10.1111/j.1365-2648.2010.05450.x. Epub 2010 Oct 15. PMID: 20946564.
Akinlotan M, Bolin JN, Helduser J, Ojinnaka C, Lichorad A and McClellan D. Cervical Cancer Screening Barriers and Risk Factor Knowledge Among Uninsured Women. J Community Health. 2017 Aug;42(4):770-778. doi: 10.1007/s10900-017-0316-9. PMID: 28155005; PMCID: PMC5494033.
Kirubarajan A, Leung S, Li X, Yau M and Sobel M. Barriers and facilitators for cervical cancer screening among adolescents and young people: a systematic review. BMC Womens Health. 2021 Mar 23;21(1):122. doi: 10.1186/s12905-021-01264-x. PMID: 33757512; PMCID: PMC7989022.
Aldohaian AI, Alshammari SA and Arafah DM. Using the health belief model to assess beliefs and behaviors regarding cervical cancer screening among Saudi women: a cross-sectional observational study. BMC Womens Health. 2019 Jan 8;19(1):6. doi: 10.1186/s12905-018-0701-2. PMID: 30621680; PMCID: PMC6323726.
Vahabi M and Lofters A. Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada. BMC Public Health. 2016 Aug 24;16(1):868. doi: 10.1186/s12889-016-3564-1. PMID: 27557928; PMCID: PMC4997745.
Devarapalli P, Labani S, Nagarjuna N, Panchal P and Asthana S. Barriers affecting uptake of cervical cancer screening in low and middle income countries: A systematic review. Indian J Cancer. 2018 Oct-Dec;55(4):318-326. doi: 10.4103/ijc.IJC_253_18. PMID: 30829264.
Chua B, Ma V, Asjes C, Lim A, Mohseni M and Wee HL. Barriers to and Facilitators of Cervical Cancer Screening among Women in Southeast Asia: A Systematic Review. Int J Environ Res Public Health. 2021 Apr 26;18(9):4586. doi: 10.3390/ijerph18094586. PMID: 33926019; PMCID: PMC8123618.
Wong G, Hayward JS, McArthur E, Craig JC, Nash DM, Dixon SN, Zimmerman D, Kitchlu A and Garg AX. Patterns and Predictors of Screening for Breast and Cervical Cancer in Women with CKD. Clin J Am Soc Nephrol. 2017 Jan 6;12(1):95-104. doi: 10.2215/CJN.05990616. Epub 2016 Dec 29. PMID: 28034851; PMCID: PMC5220661.
Wang J, Wang T, Yang YY, Chai YL, Shi F and Liu ZI. Patient age, tumor appearance and tumor size are risk factors for early recurrence of cervical cancer. Mol Clin Oncol. 2015 Mar;3(2):363-366. doi: 10.3892/mco.2014.465. Epub 2014 Nov 24. PMID: 25798268; PMCID: PMC4360871.
Baezconde-Garbanati L, Agurto I, Gravitt PE, Luciani S, Murphy S, Ochoa C, Gallegos K, Barahona R and Rodríguez Y. Barriers and innovative interventions for early detection of cervical cancer. Salud Publica Mex. 2019 Jul-Aug;61(4):456-460. doi: 10.21149/10425. PMID: 31430087; PMCID: PMC7433844.
Refbacks
- There are currently no refbacks.






